The rise of antibiotic-resistant bacteria is a looming public health crisis. Last week, the White House simultaneously released a national strategy, a report, and an executive order from the president that takes aim at this issue.
The Centers for Disease Control and Prevention has released sexually transmitted disease surveillance data for 2012, and the news is not good: Cases of chlamydia, gonorrhea, and syphilis all continued to rise.
This week, a novel approach to infertility is announced, a new vaginal ring might be able to protect from HIV transmission, and the answer to preventing drug-resistant gonorrhea may be in our own immune systems.
A new report from the the Centers for Disease Control and Prevention warns of a post-antibiotic era in which none of the drugs we have work on gonorrhea and there are no new options.
A clinical trial found that two new combinations of existing drugs can cure gonorrhea, but is this enough to combat the possibility of an outbreak of antibiotic-resistant gonorrhea?
Antibiotic-resistant gonorrhea presents a looming public health crisis that could be prevented.
The are over 700,000 cases of gonorrhea in the United States each year, and the bacteria itself has been changing and developing resistance to all but one class of antibiotics. With the likelihood that an antibiotic-resistant strain will be seen here soon, the CDC has released new treatment guidelines and a response a plan.
For years, even those in the public heath community paid little attention to gonorrhea because it was easy to prevent, easy to screen for, and easy to treat—at least it was until now. Gonorrhea is caused by wily bacteria that has become resistant to all-but-one class of antibiotics and we don’t have any others to throw at it. It’s time to take start taking notice.